Klinikum rechts der Isar der Technischen Universität München

Munich, Bavaria 81675

2 studies enrolling now · 5 studies all time

What they study most

Abiraterone Acetate, Androgens, Antineoplastic Agents, Antineoplastic Agents, Hormonal, Cancer, Cyclin-Dependent Kinase 4, Cyclin-Dependent Kinase 6, Cytochrome P-450, Enzyme Inhibitors, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Liver Stiffness

Studies at this site

• ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors — Recruiting now
• Adoptive Cell Therapy Long-term Follow-up (LTFU) Study — Recruiting now
• A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer) — Running, not enrolling
• Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial Treatment — Stopped early
• A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness — Completed